Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study (Q37393182)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 2009

Language	Label	Description	Also known as
English	Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study	scientific article published on June 2009

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study (English)

1 reference

Europe PubMed Central

20 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eric Boerwinkle

2

object named as

Eric Boerwinkle

0 references

7

object named as

Donna K Arnett

1 reference

Europe PubMed Central

20 August 2017

3

0 references

John Wiegand Eckfeldt

5

object named as

John H Eckfeldt

1 reference

Europe PubMed Central

20 August 2017

Catherine Leiendecker-Foster

6

object named as

Catherine Leiendecker-Foster

1 reference

Europe PubMed Central

20 August 2017

author name string

Amy I Lynch

1

1 reference

Europe PubMed Central

20 August 2017

Charles E Ford

4

1 reference

Europe PubMed Central

20 August 2017

publication date

1 June 2009

1 reference

Europe PubMed Central

20 August 2017

Pharmacogenetics and Genomics

1 reference

Europe PubMed Central

20 August 2017

19

1 reference

Europe PubMed Central

20 August 2017

6

1 reference

Europe PubMed Central

20 August 2017

415-421

1 reference

Europe PubMed Central

20 August 2017

Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Overview of hemostatic factors involved in atherosclerotic cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Pharmacogenetics of antihypertensive treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Characterization of the 5'-flanking region for the human fibrinogen beta gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

6 September 2017

Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

26 June 2018

Plasma lipids and blood viscosity in patients with cerebrovascular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

[The relationship between the five beta-fibrinogen gene polymorphisms and cerebral infarction].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Effect of various antihypertensive drugs on plasma fibrinogen levels in patients with essential hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

2 September 2018

Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

3 December 2018

Common Genetic Variation in Five Thrombosis Genes and Relations to Plasma Hemostatic Protein Level and Cardiovascular Disease Risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764310

3 December 2018

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Identification of beta-FBG-455G/A polymorphisms in 210 samples of Guangdong population and the relationship with plasma fibrinogen level]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Effect of beta-Fibrinogen-455 Gene Polymorphism on Plasma Fibrinogen Levels in Patients with Ischemic Stroke]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrin clot structure in patients with end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19352213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/FPC.0B013E32832A8E81

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37393182&oldid=1741957202"